Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2010-08-13 Interim / Quarterly Rep…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2010
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-June 2010. It contains comprehensive financial statements, including income statements, balance sheet summaries, cash flow analysis, and detailed management commentary on business performance, acquisitions, and market conditions. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H2 2010
2010-08-13 Swedish
Transaction in Own Shares 2010
Transaction in Own Shares Classification · 99% confidence The document is a short press release dated July 1, 2010, from Biotage AB. The key content is the disclosure that the company 'bought back 56,000 shares' and that its 'aggregated holding of own shares thereby amounts to 4,441,987 shares'. This directly relates to the company acquiring its own stock, which corresponds to the definition of 'Transaction in Own Shares' (POS). It is not a general regulatory filing (RNS) because it fits a specific category, and it is not an announcement of a report (RPA) because the core content is the transaction itself, not the publication of another document.
2010-07-01 English
Major Shareholding Notification 2010
Major Shareholding Notification Classification · 99% confidence The document is a press release dated July 1, 2010, titled 'Flaggningsmeddelande i Biotage AB (publ)' (Notification of Shareholding/Flagging Announcement). The core content explicitly states that Biotage AB repurchased 56,000 of its own shares on June 30, 2010, detailing the resulting total holding of treasury shares (4,441,987 shares, 5.02% of capital). This action—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares' (POS). It is not a general capital change (SHA) but specifically a repurchase.
2010-07-01 Swedish
Board/Management Information 2010
Board/Management Information Classification · 99% confidence The document is a press release from Biotage AB dated May 31, 2010. The core content announces changes in senior management: Anders Wikström is appointed Vice President of Operations, and Anthony Rees is appointed Chief Scientific Officer. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2010-05-31 Swedish
Board/Management Information 2010
Board/Management Information Classification · 99% confidence The document is a short press release announcing changes in senior management: the appointment of Anders Wikström as VP of Operations and Anthony Rees as Chief Scientific Officer. This directly aligns with the definition for Board/Management Information (MANG), which covers 'Announcement of changes in the company's board of directors or senior management.' The document length is short (1583 characters), but its content is the announcement itself, not a notice about another report, so RPA/RNS is not the primary classification.
2010-05-31 English
Transaction in Own Shares 2010
Transaction in Own Shares Classification · 99% confidence The document is a press release from Biotage AB dated May 24, 2010, announcing that the board has resolved to start a share buyback program. The text explicitly states the purpose is related to the acquisition and sale of the company's own shares, referencing authorization from the Annual General Meeting. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase programs.
2010-05-24 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.